205 results on '"Celestino, Joseph"'
Search Results
2. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
3. Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome-associated MSH2-deficient endometrial cancer
4. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
5. Abstract B025: IL6 signaling in pre-malignant obese endometrium and endometrial cancer
6. Abstract B024: Immune exhaustion and reversal of progestin-related immune modulation in adaptive resistance to levonorgestrel intrauterine device for treatment of atypical hyperplasia and early endometrial cancer
7. Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications
8. Learnings, Issues, and Challenges Encountered by Students and Faculty Members in the Implementation of Small Private Online Courses (SPOCs)
9. Normal Risk Ovarian Screening Study: 21-Year Update
10. Phase II Trial of Pembrolizumab in Combination with Chemotherapy for Frontline Treatment of Advanced Epithelial Ovarian Cancer
11. Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
12. Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
13. Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
14. Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
15. Data from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
16. Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
17. Abstract 2503: Tumor microenvironment composition correlates with relapse in ovarian granulosa cell tumors
18. Abstract 5473: Genomic profiling of chemotherapy-related clonal hematopoiesis in patients with high-grade serous ovarian cancer
19. Data from Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection
20. Supplementary Figure 1 from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy
21. Supplemental Movie S1 from Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection
22. Table S2 from Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection
23. Figure S1 from Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection
24. Data from A Novel Platform for Detection of CK+ and CK− CTCs
25. Supplementary Figure Legend from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy
26. Supplementary Methods, Figures 1-2, Tables 1-4 from A Novel Platform for Detection of CK+ and CK− CTCs
27. Supplementary Figure 2 from Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy
28. Supplementary Data from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
29. Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
30. Additional file 1 of Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
31. Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
32. A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
33. Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer
34. CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity
35. Abstract 5738: Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
36. Abstract 5106: Distinct molecular profiles of serum-derived extracellular vesicles in high-grade serous ovarian cancer
37. Comparative Transcriptomic Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
38. Insulin-Like Growth Factor Binding Protein 2 Promotes Glioma Development and Progression
39. If looks could kill: morphologic subtypes of high-grade serous ovarian cancer
40. Abstract 2200: NF1 copy number alterations in clinically-defined subsets of high-grade serous ovarian cancers
41. Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53
42. Chemopreventive effects of metformin on obesity-associated endometrial proliferation
43. A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
44. Abstract PO049: Compartment-specific profiling for evaluation of disrupted signaling in early stage, low-grade endometrial cancer
45. Enhanced estrogen-induced proliferation in obese rat endometrium
46. Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model
47. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
48. Abstract 2941: Functional proteomic aberrations post-chemotherapy with paclitaxel and carboplatin in patients with advanced ovarian cancer
49. Abstract 4143: Identification of molecular targets for conservative management of early stage, low-grade endometrial cancer through compartment-specific transcriptome profiling
50. Abstract B43: A serum protein biomarker signature for the detection of early stages of ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.